Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing of the deal is...
Sumitomo announces Partnership with Bukwang on its Atypical Antipsychotic Agent Lurasidone for Korea
Sumitomo Dainippon Pharma Co., Ltd. announced that the Company has concluded a license agreement with Bukwang Pharmaceutical Co., Ltd. relating to the development,sales...
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in Japan regarding the development of voclosporin for the...
College of Pharmacy, IBM help next generation of pharmacists utilize Business Intelligence Technologies
IBM and Lipscomb University College of Pharmacy announced an initiative to help train the next-generation of pharmacists on business analytics and insight-derived decision making....
Medigene Revises Collaboration With Mitsui Norin regarding its drug Veregen
Medigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on new supporting data regarding...
Recipharm partners with Sato to manufacture product for Japanese market
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and...
BioSig Technologies Announces Strategic Partnership with Mayo Clinic
BioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...